0001225208-13-003633.txt : 20130211 0001225208-13-003633.hdr.sgml : 20130211 20130211180808 ACCESSION NUMBER: 0001225208-13-003633 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130207 FILED AS OF DATE: 20130211 DATE AS OF CHANGE: 20130211 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BARD C R INC /NJ/ CENTRAL INDEX KEY: 0000009892 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 221454160 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 730 CENTRAL AVE CITY: MURRAY HILL STATE: NJ ZIP: 07974 BUSINESS PHONE: 9082778000 MAIL ADDRESS: STREET 1: 730 CENTRAL AVENUE CITY: MURRAY HILL STATE: NJ ZIP: 07974 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HENKEL HERBERT L CENTRAL INDEX KEY: 0001204528 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06926 FILM NUMBER: 13593616 MAIL ADDRESS: STREET 1: C/O INGERSOLL-RAND COMPANY LIMITED STREET 2: 155 CHESTNUT RIDGE ROAD CITY: MONTVALE STATE: NJ ZIP: 07645 4 1 doc4.xml X0306 4 2013-02-07 0000009892 BARD C R INC /NJ/ BCR 0001204528 HENKEL HERBERT L C/O C. R. BARD, INC. 730 CENTRAL AVENUE MURRAY HILL NJ 07974 1 Common Stock 2013-02-07 4 M 0 1200.0000 39.3625 A 10865.3715 D Common Stock 2013-02-07 4 M 0 1200.0000 35.7100 A 12065.3715 D Common Stock 2013-02-07 4 S 0 2400.0000 101.1362 D 9665.3715 D Option (Right to Buy) 35.7100 2013-02-07 4 M 0 1200.0000 0.0000 D 2013-07-09 Common Stock 1200.0000 0.0000 D Option (Right to Buy) 39.3625 2013-02-07 4 M 0 1200.0000 0.0000 D 2013-12-10 Common Stock 1200.0000 0.0000 D Includes 19.3783 shares acquired under the Company's Dividend Reinvestment Plan from December 12, 2012 to February 7, 2013. Represents the weighted average sales price for price increments ranging from $101.09 to $101.16. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Award/Grant pursuant to the 2005 Directors' Stock Award Plan, as amended and restated (formerly known as the 1988 Directors' Stock Award Plan). This option, previously reported as covering 600 shares at an exercise price of $71.42, was adjusted to reflect the 2-for-1 stock split on May 28, 2004. Options vested in three equal annual installments beginning on July 9, 2004 and are currently exerciseable. This option, previously reported as covering 600 shares at an exercise price of $78.725, was adjusted to reflect the 2-for-1 stock split on May 28, 2004. Options vested in three equal annual installments beginning on December 10, 2004 and are currently exerciseable. Myra McGinley, Attorney-in-Fact 2013-02-11